multiple myeloma

News

Sanofi wins appeal in spat with NICE over Sarclisa

Sanofi has taken a small step towards potentially overturning a recent rejection by NICE for NHS use of Sarclisa as a treatment for relapsed and refractory multiple myeloma (RRMM).

News

J&J bids to add smouldering myeloma to Darzalex label

Johnson & Johnson has reported positive phase 3 data with Darzalex in smouldering multiple myeloma (SMM), just before filing applications for the drug in this indication in Europe and t

News

Joy as NICE lifts restrictions on myeloma drug Elrexfio

Patients in England and Wales with multiple myeloma are celebrating a decision by NICE to relax strict restrictions on eligibility to receive Pfizer's Elrexfio.

R&D

Myeloma multiplex leukaemia cancer 3D render

The future of multiple myeloma is personalised, but we must ...

It’s true that we’ve come a long way in recent years when it comes to treating multiple myeloma.

News

Sanofi's Sarclisa gets one up on rival Darzalex in myeloma

Sanofi's Sarclisa has been an also-ran in the anti-CD38 antibody class behind Johnson & Johnson and Genmab's blockbuster Darzalex, but now has a chance to steal some of the spotlight.

News

NICE updates on controversial multiple myeloma decisions

NICE has defended a trio of decisions on new therapies for multiple myeloma, which saw two drugs approved for restricted use in England and Wales and a third turned down altogether.

Sanofi wins appeal in spat with NICE over Sarclisa

J&J bids to add smouldering myeloma to Darzalex label

Joy as NICE lifts restrictions on myeloma drug Elrexfio

The future of multiple myeloma is personalised, but we must ...

Sanofi's Sarclisa gets one up on rival Darzalex in myeloma

NICE updates on controversial multiple myeloma decisions

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

multiple myeloma

Editor's Picks